Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EQT Corporation Common Stock (EQT) vs Cassava Sciences Inc (FLNA) Price & Performance

EQT Corporation Common StockTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

EQT Corporation Common Stock vs Cassava Sciences Inc — how do they compare? EQT Corporation Common Stock trades at $52.99 (market cap $33.11B), while Cassava Sciences Inc trades at $0.83 (market cap $39.40M). The key difference: EQT Corporation Common Stock is far larger — about 840.4× Cassava Sciences Inc's market cap, and EQT Corporation Common Stock pays a 1.25% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 0 Days and Cassava Sciences Inc for 37 Days on average.

EQTFLNA
Market Cap
$33.11B$39.40M
Volume
7,642,959759,018
Sector
EnergyHealth
52-Week High
$67.93$4.64
52-Week Low
$48.56$0.68
Typical Hold Time
0 Days37 Days
Enterprise Value
$38.66B-$43.28M
Dividend Yield
1.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EQT Corporation Common Stock

No Aura AI signal available yet.

Cassava Sciences Inc

Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).

The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQT
100% Buy0% Sell
Avg holding period · 0 Days
FLNA
73% Buy27% Sell
Avg holding period · 37 Days

About EQT Corporation Common Stock

EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.

Read more on EQT →

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →